Strix
26.1K

CVE-2026-21923

MEDIUMCVSS 6.5/10EPSS 0.22%

Last modified

CVE-2026-21923 is a medium-severity vulnerability rated 6.5/10 on the CVSS scale. Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. EPSS estimates a 0.22% chance of exploitation in the next 30 days.

Description

Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences Central Designer accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Central Designer accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N).

Metrics

CVSS 3.1
6.5/10

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N

EPSS Probability
0.22%

12.7th percentile

Probability of exploitation in the next 30 days. Learn more

Affected Software

VendorProductVersions
OracleLife Sciences Central Designer7.0.1.0

References

Timeline

Published
Last Modified
Status
Analyzed

Frequently Asked Questions

What is CVE-2026-21923?
Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences Central Designer accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Central Designer accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N).
How severe is CVE-2026-21923?
CVE-2026-21923 has a CVSS score of 6.5/10 (MEDIUM severity). The EPSS model estimates a 0.22% probability of exploitation in the next 30 days.
How do I fix CVE-2026-21923?
Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.

Are you affected by CVE-2026-21923?

Run a free Strix scan to check your systems for this vulnerability.

Scan your code now

Source: NVD / NIST